Effects of Combined Use of Trospium Chloride and Melatonin on In Vitro Contractility of Rat Urinary Bladder

Urology

Volumn 75, Issue 4, 2010, Pages 873-877

  Onur, Rahmi ^a   Ozcan, Mete ^a   Tuygun, Ugur ^a   Ozan, Tunç ^a   Ayar, Ahmet ^a   Orhan, Irfan ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; MELATONIN; TROSPIUM CHLORIDE;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLADDER CONTRACTION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; MALE; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; RAT; URINE INCONTINENCE;

ANIMALS; DRUG COMBINATIONS; DRUG SYNERGISM; MALE; MELATONIN; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; NORTROPANES; RATS; RATS, WISTAR; URINARY BLADDER;

EID: 77950297013     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.08.086     Document Type: Article

References (26)

1. Abrams P., and Andersson K.E. Muscarinic receptor antagonists for overactive bladder. BJU Int 100 (2007) 987-1006
2. Su X., Stein R., Stanton M.C., et al. Effect of partial outlet obstruction on rabbit urinary bladder smooth muscle function. Am J Physiol Renal Physiol 284 (2003) 644-652
3. Sibley G.N. Developments in our understanding of detrusor instability. Br J Urol 80 (1997) 54-61
4. Wein A.J. Diagnosis and treatment for the overactive bladder. Urology 62 (2003) 20-27
5. Chapple C., Khullar V., Gabriel Z., et al. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48 (2005) 5-26
6. Semercioz A., Onur R., Ayar A., et al. The inhibitory role of melatonin isolated guinea-pig urinary bladder: an endogenous hormone effect. BJU Int 94 (2004) 1373-1376
7. Cardozo L., Chapple C.R., Toozs-Hobson P., et al. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial. BJU Int 85 (2000) 659-664
8. Halaska M., Ralph G., Wiedemann A., et al. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 20 (2003) 392-399
9. Amend B., Hennenlotter J., Schäfer T., et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol 53 (2008) 1021-1028
10. Hassouna M., Nishizawa O., Miyagawa I., et al. Role of calcium ion antagonists of the bladder detrusor muscle: in vitro and in vivo study. J Urol 135 (1986) 1327-1335
11. Andersson K.E., and Wein A.J. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 56 (2004) 581-631
12. Abrams P., Blaivas J.G., Stanton S.L., et al. Standardization of terminology of lower urinary tract function. Neurourol Urodyn 7 (1988) 403-427
13. Wagner T.H., and Hu T. Economic costs of urinary incontinence in 1995. Urology 51 (1998) 355-361
14. Alloussi S., Laval K.U., Eckert R., et al. Trospium chloride (Spasmo-lyt) in patients with motor urge syndrome (detrusor instability): a double-blind, randomised, multicentre, placebo-controlled study. J Clin Res 1 (1998) 439-451
15. Beckmann-Knopp S., Rietbrock S., Weyhenmeyer R., et al. Inhibitory effects of trospium chloride on cytochrome P450 in human liver microsomes. Pharmacol Toxicol 85 (1999) 299-304
16. Drake M.J. Emerging drugs for treatment of overactive bladder and detrusor overactivity. Expert Opin Emerg Drugs 13 (2008) 431-446
17. Sanguinetti M.C., and Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 440 (2006) 463-469
18. Satake N., Shibata S., and Takagi T. The inhibitory action of melatonin on the contractile response to 5-hydroxytryptamine in various isolated vascular smooth muscles. Gen Pharmacol 17 (1986) 553-558
19. Ayar A., Martin D.J., Ozcan M., et al. Melatonin inhibits high voltage activated calcium currents in cultured rat dorsal root ganglion neurones. Neurosci Lett 313 (2001) 73-77
20. 1, cyclic AMP, dibutyrylcyclic AMP and theophylline on rat seminiferous tubular contractility in vitro. Biol Reprod 19 (1978) 217-222
21. Barun S., Ekingen G., Vural I.M., et al. The effects of melatonin on electrical field stimulation-evoked biphasic twitch responses in the ipsilateral and contralateral rat vasa deferentia after unilateral testicular torsion/detorsion. Naunyn Schmiedebergs Arch Pharmacol 371 (2005) 351-358
22. Ouyang H., and Vogel H.J. Melatonin and serotonin interactions with calmodulin: NMR, spectroscopic and biochemical studies. Biochim Biophys Acta 1383 (1998) 37-47
23. Korkmaz A., Reiter R.J., Topal T., et al. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15 (2009) 43-50
24. Seabra M.L., Bignotto M., Pinto Jr. L.R., et al. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 29 (2000) 193-200
25. Reiter R., Gultekin F., Flores L.J., et al. Melatonin: potential utility for improving public health. TAF Prev. Med Bull 5 (2006) 131-158
26. Tan D.X., Reiter R.J., Manchester L.C., et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2 (2002) 181-197